Twitter Linkedin-in

Biomarkers UK: In-Person

27 - 28 February 2023 | Manchester , UK
Part of the
Biomarkers Series
Biomarkers US:
In-Person
Biomarker Analysis Europe:
In-Person
Biomarkers For NASH
Symposium
Biomarkers UK:
In-Person
Book Now
Biomarkers UK
27 - 28 February 2023 | Manchester, UK
Europe’s flagship event for Biomarker Research Returns: the must-attend forum to engage with the latest trends transforming biomarker and translational research
Download Agenda
Register

Biomarkers UK: In-Person, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

It includes over 90 cutting-edge presentations and discussion sessions, 8+ hours of valuable networking sessions and an exhibition hall showcasing 50+ vendor companies.

18th Annual Biomarkers Congress

16th Annual
Biomarkers Congress

An outstanding and comprehensive programme showcasing the essential role of biomarkers to quicken timelines and ensure clinical success in drug development

2nd Annual
Genomic Markers Congress

With key advancements ensuring continuous developments and new data in this field, pioneers in genomic technologies and markers will share their experiences across the development pipeline to facilitate precision medicine

Digital Biomarkers & Pathology Congress

To accelerate drug development and clinical uptake by bringing together discovery, diagnostics and clinical development collaborators, directors and leaders from Pharma, biotech and healthcare institutions working in this field

Benefits to Attending...

  • Hear from and meet with the key industry and academic innovators in biomarkers, translational medicine, clinical development and diagnostics
  • Discover the latest integration of biomarkers in drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, NASH and immunology
  • Gain novel insights into key biomarkers for detection, monitoring and diagnosis, including innovative applications of digital markers. Further talks look at early detection of cancer
  • Discuss the use of biomarkers in preclinical and clinical development: trial design & data analysis, assay development, patient stratification & selection and the role of safety & efficacy markers
  • Supported digitally on our immersive online event platform, with headline talks live-streaming from the auditorium, selected presentations available to watch on-demand and extensive networking features
  • Benefit from a highly interactive event programme, with a selection of panels, workshops and roundtables on key areas for discussion within the industry

Agenda at a Glance

Day One 

  • Gain insights into the latest biomarker tools and applications within oncology and immunology
  • Workshop: Biomarker Validation Biomarkers for Diagnostic Development
  • Diagnostic development: companion, tissue & PoC
  • Early detection strategies
  • Regulatory updates with CDx in Clinical Development
  • Diagnostics Therapeutics
  • Transforming clinical development through biomarker driven clinical trial design
  • Safety & efficacy biomarkers and translational strategies

Day Two

  • Case studies in biomarker discovery and validation in neuroscience and
    NASH
  • Insights into emerging modalities, including cell & gene therapies and rare disease
  • Workshop: Biomarker Validation
  • Multiplexing technologies, Flow cytometry and Mass spectrometry
  • Immunoassays and screening processes
  • Assay development & validation
  • Digital pathology in immuno-oncology and oncology biomarker
    development
  • Bridging the gaps between research, development and clinical uptake
  • Overcoming challenges, including data analysis
  • Integrating AI into image analysis
  • AI-Based Technologies For Biomarker Research

Key Speakers

The 2023 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the confirmed speakers for 2022’s event:

Dmitri Mikhailov

Dmitri Mikhailov

Director, Head Biomarker Coordination
Novartis
Mark Fidock

Mark Fidock

Vice President, Diagnostic Development, Precision Medicine & Biosamples
AstraZeneca
Isabella Gashaw

Isabella Gashaw

Principal Clinical Biomarker Lead Cardiometabolism
Boehringer Ingelheim
Mads Ropke

Mads Ropke

Senior Principal Clinical Pharmacologist, Clinical Pharmacology
Leo Pharma
Clare Balendran

Clare Balendran

Vice President, Head of Translational Medicine
Novo Nordisk
Richardus Vonk

Richardus Vonk

Vice President, Head Oncology Statistics and Data Management
Bayer AG

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception
Enquire

Supported Digitally

Can't attend in-person? Our fully featured online platform runs alongside the event with access to all digital presentations and content from the in-person event.

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
Great organization, excellent networking, speakers, work streams, great refreshments. I enjoyed the new pre-conference Directors Club networking event and was so happy that the roundtable think tank event was a full hour! Overall a great conference and excellent venue.
Associate Director, Research & Development Procurement, Precision Medicine Novartis
The agenda was very well organised, presentations and workshop were scientifically relevant, interesting and well presented. Ample time was allowed for networking, for reviewing posters, visiting the booths and for 1:1.
Clinical Science DirectorOno Pharma UK Ltd
I liked the enthusiasm of the speakers, and the “community spirit” at the event. The facility itself with the large hall organization and meeting rooms all around was very easy to navigate.
EU Rheumatology Medical Affairs LeadSanofi
I thought there was a great variety of vendors and speakers. The round table discussion and workshop around biomarker qualification were excellent!
Vice President, Accelerator and Pharma ServicesQuanterix
Great networking capability with relevant attendees. It was a well-organised event and the presentations were also relevant!
Business Development ManagerHistologiX
The numbers of delegates as well as the ratio of sponsors to service providers was good. I liked the venue (including a private room for 1-2-1 meetings), and the presentations had good variety. The networking dinner was relaxed and the magicians were great.
Senior Director, MarketingCovance, Inc

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Free Live Webinar

Development and Implementation of Flow Cytometry Assays for Use In Clinical Trials

Thursday 21st May | 3:30pm BST

Hosted by Nicholas Jones,
Director of Global Flow Cytometry – Pharma Services, NeoGenomics Laboratories

Register (Free)